Withdrawal-emergent dyskinesia in a patient on risperidone undergoing dosage reduction.
A 23-year-old, white male with history of paranoid schizophrenia developed a withdrawal-emergent dyskinesia during a dose reduction of risperidone. The implications of this with regard to future risk of tardive dyskinesia (TD) and the potential association of risperidone with TD are discussed.
Anand
V S
VS
SUNY Health Science Center at Syracuse, Department of Psychiatry, Syracuse 13210, USA.
Dewan
M J
MJ
D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D008297:Male; D018967:Risperidone / Q000008:administration & dosage / Q000009:adverse effects*; D012563:Schizophrenia, Paranoid / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy
D014150:Antipsychotic Agents; D018967:Risperidone